There are only few reports of scattered cases of thyrotoxicosis due to weight reducing drugs containing thyroid preparation throughout the world and there have been few experimental studies on this condition. This paper summarizes the findings on more than one hundred cases observed recently in Japan and detailed observations on illustrative cases. We examined eighteen patients who were admitted to Tokushima University Hospital and made follow up studies on them for several years after their discharge from hospital. Records of 105 other cases were collected in cooperation with medical and psychiatrical clinics of medical school and public hospitals throughout Japan. These records included the patients who had thyrotoxic symptoms but without apparent goiter and had self-medication of thyroid drugs recognized. Data on the latter cases were chiefly analyzed according to age of incidence, geographical distribution and sort of thyroid preparations.
Illustrative Cases
The case reported here illustrates the typical course of thyroid intoxication. 
Clinical Observations
Clinical observations on 18 cases are summarized as follows.
Symptoms: The patients visited the physicians complaining of palpitation, emaciation, psychic irritability, menstrual abnormalities, diarrhea and loss of hair. Loss of weight was especially prominent and some cases had become half their usual weight. Transient psychic abnormalities were observed in 33% of the patients. These included restlessness, nervousness, agitation and depression. One case suffered from pseudohallucinations. Two cases were acutually admitted to mental institutions with suspected psychosis but they all recovered from psychological abnormalities after cessation of the thyroid drugs.
Several patients first visited their doctors complaining of oedema of the face, fatigability, obstipation, coldness of the extremities and amenorrhea. The main details of these cases are given in Table I . In a few patients of these cases we had the impression that physical 
Discussion
Weight reducers containing thyroid extracts have widely been used throughout the world and there are reports of isolated cases of toxicity. In the United States of America sale of these drugs is now illegal under the Federal law. However, no previous cases of this type have been reported in Japan. The clinical status of this condition has been termed thyrotoxicosis factitia but we know of no cases of toxicosis due to weight reducers containing Jodocasein.
Jodocasein was investigated by Reineke (1946) and others. Clinically, it has occasionally been used in treatment of cases of hypothyroidism in Japan. In physiological tests using tadopoles, Minato and Tanaka (1950) demonstrated that the physiological effects of Jodocasein was more active than desiccated thyroid. And we also noticed in animal experiments that Jodocasein was equally effective on weight reduction with desiccated thyroid (Miyoshi and Ohno, 1966) . So the hormonal activity of 1 tablet of Baset Super was presumed equivalent to more than 40mg of desiccated thyroid. Many patients took 10 to 20 tablets of Baset Super a day, which are equivalent to about 0.4 to 0.8g or more of desiccated thyroid. This is 2 to 3 times as much as the prescribed dose and the patients were easily in a toxic state. The clinical condition of suppressed thyroidal activity and other sequelae observed in the presented cases long after discontinuation of thyroid drugs seemed to continue longer than previously reported (Johnston et al., 1951) . The term thyrotoxicosis factitia refers to the thyrotoxic state only, so we proposed the term "Thyreoidismus Medicamentosus" for the whole course of this condition of thyroid intoxication, including the toxic state, suppressed thyroid state, psychic abnormalities and other sequelae. We may summarize the whole course as follows (Fig. 1) .
